Jennewein accuses Nestlé of infant formula patent infringement

By Will Chu

- Last updated on GMT

©iStock/
©iStock/

Related tags Jennewein Nestlé HMO

Jennewein Biotechnologie has filed a patent infringement suit against Nestlé concerning the unauthorised use of a human milk oligosaccharide (HMO) purification method for infant formula.

Jennewein, which filed the suit with the Mannheim regional courts last week, claims that Nestlé’s infant formula brand Beba Supreme contains the HMOs 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) purified by the patent-protected process.

In addition, the German firm claims to have evidence that Nestle infant formulas marketed under different trade names also include the two HMOs produced by the purification method.

“As Nestlé offers its infant food containing human milk oligosaccharides not just in Germany, Jennewein currently investigates measures against the assumed infringement of its corresponding foreign patents by the manufacturing of products such as Illuma, SMA, NAN and Gerber Good Start,”​ says Jennewein.

Purity of at least 80 %’

The firm’s patent attorney Dr Andreas Hübel explains that the exact process protected by the patents (EP 2896628​ and EP 3131912​) is a method for the purification of neutral HMOs such as 2’-FL and LNnT from a fermentation broth.

“This process involves removal of biomass from the fermentation broth, subjecting the cell-free fermentation broth to ion exchange treatment, followed by electrodialysis and/or nanofiltration,”​ he says.

“Pursuant to one of the patents, the process further involves spray-drying the HMO. The process leads to a preparation of a neutral HMO from the fermentation broth having a purity of at least 80 %.”

“It is our understanding that Nestle uses said two neutral HMOs for the production of their HMO-containing infant formula, wherein said HMOs have been produced by a process that involves the purification scheme that is proprietary to Jennewein Biotechnologie,”​ adds Dr Hübel.

Jennewein now request that Nestlé Nutrition and its holding company Nestlé Deutschland AG cease the use of the HMOs that infringe Jennewein’s intellectual property rights.

Responding to the allegations, a spokesperson for Nestlé said that the company had not received any official notification on the matter and were therefore unable to comment.

Related news

Show more

Related products

show more

Healthy ageing: a food supplement from Biofarma Group

Healthy ageing: a food supplement from Biofarma Group

Content provided by Biofarma Group | 26-Feb-2024 | White Paper

Worldwide, the percentage of people over 65 and 80 years of age is steadily increasing. However, as society continues to age, people do not necessarily...

Unlock the business potential of the protein trend

Unlock the business potential of the protein trend

Content provided by Valio | 24-Jan-2024 | White Paper

Read our white paper to learn how to overcome taste and texture challenges in protein products — and how to commercialise the protein trend by making delicious...

4 reasons children need MFGM, according to science

4 reasons children need MFGM, according to science

Content provided by Valio | 29-Sep-2023 | White Paper

In this white paper, Dr Anu Turpeinen discusses the ample scientific evidence showing why milk fat globule membrane (MFGM) is essential for children’s...

Related suppliers

Follow us

Products

View more

Webinars